Skip to main content
Future Journal of Pharmaceutical Sciences

Table 7 Inhibitory effect of OVMS against S. aureus

From: DoE approach for development of localized controlled release microspheres of Vancomycin for treatment of septic arthritis

Formulation

Zone of inhibition (cm)

Marketed formulation (IV powder)

1.9 ± 0.1

Test formulation (VMS)

1.5 ± 0.1

  1. Data are represented as mean ± SD (n = 3)
Back to article page